Literature DB >> 8608198

Measurement of S-100 protein in human blood and cerebrospinal fluid: analytical method and preliminary clinical results.

U Missler1, M Wiesmann.   

Abstract

An immunofluorometric sandwich assay for determination of S-100 protein in cerebrospinal fluid (CSF) and blood is described. The lower detection limit was 0.015 micrograms/l of S-100 protein. Intra-assay and inter-assay imprecision (coefficients of variation, CVs) were 2.1 to 3.2% and 7.8 to 11.6%, respectively. S-100 protein recovery in cerebrospinal fluid was 94 to 103%. In blood the recovery varied from 67 to 96%, depending on blood samples used and the concentration of S-100 protein. The best recovery in blood was found using heparinized plasma. In healthy subjects 0.098 +/- 0.11 micrograms/l (mean +/- SD) of S-100 protein was detected (n = 30). In the CSF of otherwise healthy patients undergoing a myelography for lumbar pain 1.43 +/- 0.49 micrograms/l (mean +/- SD) of S-100 protein was found. Preliminary results from longitudinal studies on S-100 protein in neurosurgical patients indicate a positive correlation between S-100 protein blood levels and clinical course. Thus, the determination of S-100 protein in blood appears to be helpful in the monitoring of patients with neuronal damage.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8608198     DOI: 10.1515/cclm.1995.33.10.743

Source DB:  PubMed          Journal:  Eur J Clin Chem Clin Biochem        ISSN: 0939-4974


  2 in total

1.  Failure of intraoperative jugular bulb S-100B and neuron-specific enolase sampling to predict cognitive injury after carotid endarterectomy.

Authors:  Daniel H Sahlein; Eric J Heyer; Anita Rampersad; Christopher J Winfree; Robert A Solomon; Alan I Benvenisty; Donald O Quest; Evelyn Du; E Sander Connolly
Journal:  Neurosurgery       Date:  2003-12       Impact factor: 4.654

2.  The luminescence immunoassay S-100: a sensitive test to measure circulating S-100B: its prognostic value in malignant melanoma.

Authors:  J M Bonfrer; C M Korse; O E Nieweg; E M Rankin
Journal:  Br J Cancer       Date:  1998-06       Impact factor: 7.640

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.